T 0516/11 (Anticarcinoma antibodies/OTTAWA HEALTH) of 07.05.2015

European Case Law Identifier: ECLI:EP:BA:2015:T051611.20150507
Date of decision: 7 May 2015
Case number: T 0516/11
Petition for review of: -
Application number: 04761652.9
IPC class: G01N 33/574 C07K 14/245 C12N 15/13 A61K 47/48 C07K 19/00 A61P 35/00 C07K 16/30
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Anticarcinoma antibodies and uses thereof
Applicant name: Ottawa Health Research Institute
Opponent name: -
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 56 European Patent Convention Art 87
Keywords: Remittal to the department of first instance - (yes)
Substantial procedural violation (no)
Appealed decision sufficiently reasoned (yes)
Catchword: -
Cited cases: T 0367/91 T 0939/92 T 0890/02 T 0411/04
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division for further

prosecution.

3. The request for reimbursement of the appeal fee is rejected.